60
[MeSH:noexp]
OR
diagnosis,differential
[MeSH:noexp]
OR
diagnosis[
Subheading:noexp])))
Recuperado:
1138
Selecionado:
12
QUESTÃO 3: Qual o papel dos autoanticorpos
no diagnóstico precoce e no seguimento dos
pacientes com ES?
(((Scleroderma, Systemic OR Systemic Sclerosis)
AND
specificity[Title/Abstract])
OR
((Scleroderma, Systemic OR Systemic Sclerosis)
AND
(classification
OR
criteria)
AND
(sensitiv*[Title/Abstract] OR sensitivity and
specificity[MeSH
Terms]
OR
diagnos*[Title/Abstract]
OR
diagnosis
[MeSH:noexp]
OR
diagnostic
*
[MeSH:noexp]
OR
diagnosis,differential
[MeSH:noexp]
OR
diagnosis[
Subheading:noexp])))
Recuperado:
1138
Selecionado:
28
QUESTÃO 4: Quais tratamentos são benéficos
para o espessamento cutâneo na ES?
(Scleroderma, Systemic OR Systemic Sclerosis)
AND (cutaneous OR skin OR thick* OR tissue)
AND (randomized controlled trial[Publication
Type] OR (randomized[Title/Abstract] AND
controlled[Title/Abstract]
AND
trial[Title/Abstract]))




